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ABSTRACT
Dyslipidemia is major problem among population those have sedentary life style as well as in diabetics. Bougainvillea 
spectabilis is most commonly found in India as an ornamental plant and has got anti-diabetic action due to presence of one 
insulin mimicking agent D-pinitol (3-O-methyl-chiroinositol). The present investigation was undertaken to evaluate the 
effect of alcoholic extract of leaves of Bougainvillea spectabilis (AEBSL) on serum lipid profile in albino rats fed with 
high fat diet (HFD) and to compare it with a standard hypolipidaemic drug simvastatin. Thirty healthy albino rats of both 
sexes (100-200 g) were randomized into 5 groups of 6 animals each. The groups were treated as follows: Group A: normal 
diet (ND); Group B: HFD (vanaspati ghee + coconut oil mixture in ratio of 3:2 at 10 ml/kg/day); Group C: HFD+ AEBSL 
(100 mg/kg/day); Group D: HFD + AEBSL (200 mg/kg/day); Group E: HFD + simvastatin (1.8 mg/kg/day). Lipid profile 
was estimated  after  8 weeks  of treatment.  AEBSL  showed  a significant (p<0.01) reduction in total cholesterol (TC), 
Triglyceride (TG), Low density lipoprotein (LDL), Very low density lipoprotein (VLDL) levels and significant (p<0.01) 
increase in high density lipoproteins (HDL) in hypercholesteromic rats (Group C and Group D). AEBSL 200 mg/kg/day 
found to be  more effective than  AEBSL 100  mg/kg/day.  There  is also significant improvement in atherogenic index 
(p<0.01) and increases the percentage of protection AEBSL treated animals. Alcoholic extract of leaves of Bougainvillea 
spectabilis leaves have excellent lipid lowering potentiality.
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INTRODUCTION
Atherosclerosis  remains  the  major  cause  of  death  and 
premature  disability  in  developed  societies.  Current 
predictions  estimate  that  by  the  year  2020,  cardiovascular 
diseases  notably  atherosclerosis,  will  become  the  leading 
global cause of total disease burden. Coronary atherosclerosis 
causes myocardial infarction and angina pectoris; strokes and 
transient  cerebral  ischemia  are  due  to  cerebral 
atherosclerosis.  Intermittent  Claudication  and  gangrene  are 
dreaded  sequale  of  atherosclerosis  occuring  peripherally. 
Abnormalities  in  plasma lipoproteins  and  derangements  in 
lipid metabolism rank among the most firmly established and 
the best understood risk factors for atherosclerosis.
[1]
During  the  past  few  decades,  traditional  systems  of 
medicines have become a topic of global importance. Current 
estimates suggest that, in many developing countries, a large 
proportion  of  the  population  relies  heavily  on  traditional 
practitioners and medicinal plants to meet primary health 
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care needs. Although modern medicine may be available in 
these  countries,  herbal  medicines  (Phytomedicines)  have 
often  maintained  popularity  for  historical  and  cultural 
reasons.
[2]
The genus Bougainvillea is a native of South America and 
derived its name from Louis Antione de Bougainville (1729–
1811), an admiral in the French Navy who encountered the 
plant in Brazil in 1768 and first introduced it to the rest of the 
world.
[3] The genus Bougainvillea in the Nyctaginaceae (4 
O’ clock) family of plants has 18 species, with three that are 
horticulturally  important  B.  spectabilis,  B. glabra  and  B.
peruviana.
[4] The Bougainvillea spectabilis leaves (BSL) are 
reported to have medicinal properties viz. anti-diabetic
[5-7], 
antiviral
[8], antibacterial
[9], anti-inflammatory
[10], larvicidal
[11] and  anti-fertility  potential.
[12] D-pinitol  (3-o-methyl-
chiroinositol)  an  active  constituent  has  been  isolated  from 
leaves  of  BS.
[7,  13] In  spite  of  the  isolation  of  the 
hypoglycaemic  principle  of  BSL,  the  crude  extract  of  the 
leaves  is  still being  consumed in  Northern  part  of  Nigeria 
(particularly  among  the  Nupe  people  of  Niger  State)  as  a 
remedy for diabetes.
[14] Information also exists about the B.
glabra having  antiulcer,  anti-diarrhoeal,  and  anti-microbial 
properties
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hypolipidemic  ativities. 
[16] Geethan  PKMA et  al,  have 
demonstrated  the  antihyperlipidemic  effect  of  D-pinitol  in 
streptozotocin induced type II diabetic Wistar rats.
[17]
The  abnormal  lipoprotein  profile  associated  with  insulin 
resistance, known as diabetic dyslipidemia, accounts for part 
of  the  elevated  cardiovascular  risk  in  patient  with  type  2 
diabetes  mellitus. 
[1] Though  different  types  of 
hypolipidaemic agents are available to treat hyperlipidemia, 
there  is  an  increased  demand  by  people  to  use  natural 
products. Moreover, this plant extract has already shown its 
anti-diabetic potentiality and diabetes is invariably associated 
with Dyslipidemia. So, this plant material will be a valuable 
point of interest in near future. Keeping in view the above 
idea, the present study has been undertaken to evaluate the 
effect of AEBSL on serum lipids in albino rats fed with high 
fat  diet and to  compare  it  with  a  standard  hypolipidaemic 
drug simvastatin.
MATERIALS AND METHODS
Plant  material: Fresh,  mature,  healthy  and  good  quality 
Bougainvillea  spectabilis leaves were  procured  from  the 
Assam  Medical  College  &  Hospital  campus,  during  the 
months of May - June 2006 and botanically identified and 
authenticated.  Leaves  were  washed  thoroughly  and  shade 
dried,  then  powdered  by  electrical  grinder.  500  g  of 
powdered leaves were soaked in sufficient quantity of 70% 
ethanol and percolated.
[5] A greenish, extract was obtained. 
The  extract  was  collected  in  glass  Petri  dishes,  kept  in  a 
vacuum dessicator. The yield at the end of extraction was 90 
grams,  18%  of  the  dry  powder.  A homogenous  aqueous 
suspension  of  the  extract  was  made  before  being 
administered to the experimental animals.
Acute  toxicity  study:  AEBSL  were  tested  for  acute  oral 
toxicity as per our previous study.
[5] LD50 was calculated and 
two doses of 100 mg/kg and 200 mg/kg were chosen for the 
present study.
Method  of  Preparation  of  Simvastatin  Suspension:  The 
stock  solution  was  prepared  by  dissolving  20  mg  of 
simvastatin in 70 ml of normal saline and used as a standard 
drug in a dose of 1.8 mg/kg body weight for the respective 
group. The daily dose of simvastatin for rats was calculated 
by  extrapolation  from  the  human  dose  (20  mg/day)  as 
described by Ghosh.
[18]
Method of Preparation of High Fat Diet: Edible coconut 
oil and vanaspati ghee were procured from the market and a 
mixture of the two was prepared in a ratio of 2: 3 respectively 
v/v as per method of Shyamala et al. 
[19] This high fat diet at 
a dose of 10 ml/kg body weight was fed to the animals per 
orally  daily  in  addition  to  normal  diet  for  the  entire 
experimental period to produce hyperlipidemia.
Experimental Design: The experiment was carried out for a 
period of 8 weeks. 30 numbers of healthy albino rats (Wistar 
strain) of both sex and weighing approximately 150–200 gm 
were  collected  from  the  Central  Animal House  of  Assam 
Medical  College,  Dibrugarh.  The animals  were allowed  to 
acclimatize  to  the  laboratory  environment  for  one  week. 
They were provided with a standard diet consisting of Bengal 
gram, wheat, maize and carrot. Water was given ad libitum 
during  the  entire  period  of  the  experiment.  Animals  were 
weighed, recorded, numbered and randomly divided into five 
groups of 6 animals each. All the animals were taken care of 
under  ethical  consideration  and  the  experimental  protocol 
was duly approved by institutional ethic committee.
Group–A: (Normal Control Group): Normal saline 10 ml/kg 
body weight/day. 
Group–B: (Hyperlipidaemic  Control Group):  High fat diet 
(10 ml/kg body weight/day).
Group–C:  (Hyperlipidaemic  Test  Group):  High  fat  diet  + 
AEBSL (100mg/kg/day).
Group–D:  (Hyperlipidaemic  Test  Group):  High  fat  diet  + 
AEBSL (200mg/kg/day).
Group–E:  (Standard  Drug  Group):  High  fat  diet  + 
Simvastatin (1.8 mg/ kg/day)
All  the  animals  used  for  the  experiment  were  kept  under 
observation  for  daily  food  intake.  The  drugs  were 
administered to the animals in the doses given above daily, 
by  means  of  an  intragastric  feeding  tube.  At  the  end  of 
experiment, all the animals were taken group wise and blood 
collected  from  each  of  them  for  assessing  the  various 
parameters of lipid profile. 
Method  of  collection  of  Blood  and  Biochemical 
estimation: Blood was collected from the orbital sinus with 
the help of a capillary tube by pressing the thumb behind the 
angle of the jaw resulting in the engorgement of the retro-
orbital plexus.
[18]
After  separation  of  serum  from  blood,  the  various 
biochemical parameters were estimated in the Department of 
Pathology, Assam Medical College by using standard kits of 
Randox, Mumbai. The parameters of lipid profile which were 
observed were Total Serum Cholesterol (TC), Triglycerides 
(TG),  Low  Density  Lipoprotein  Cholesterol  (LDL),  Very 
Low Density Lipoprotein Cholesterol (VLDL), High Density 
Lipoprotein Cholesterol (HDL) and Atherogenic Index (AI). 
Serum LDL and VLDL were estimated by calculation based 
on Friedwald et al.
[20] Atherogenic Index was calculated by 
using  the  formula  of  Schulpis et  al. 
[21] Percentage  of 
protection was calculated based on Dhandapani et al. 
[22]
LDL mg/dl = Total cholesterol – HDL - TG/5.
VLDL mg/dl = Serum triglycerides
                         5
Atherogenic Index (AI) = Total Cholesterol – HDL
                                             HDL
AI of experimental control- AI 
of treated group
Protection (%) = × 100
AI of control
Statistical  Analysis- Data  obtained  were subjected  to 
computerized (Graph Pad Prism 5 Demo version) One-way 
Analysis  of  Variance  (ANOVA)  followed  by  Dunnet’s 
multiple  comparison test.  The  chosen level  of  significance 
was p < 0.01.
RESULTS
Results of serum lipids estimation were reported as Mean 
SEM (standard error of mean) of 6 animals at a time from 
each group. The statistical significance between groups was 
analyzed  using  one–way  ANOVA,  followed  by  Dunnet’s 
multiple comparison tests. The significance was expressed by 
‘p’ values, as mentioned in the table and ‘p’ value of < 0.01 
was  considered  as  significant.  Table 1  has  shown  the 
different serum lipid parameters at the end of the 8th week of 
the experiment and Table 2 has shown the atherogenic index 
and  increased  in  percentage  of  protection  in  each  treated 
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Table 1: Effects of AEBSL on Serum Lipids at the end of 8th Week
Group & Drugs Total
Cholesterol Triglycerides HDL LDL VLDL Atherogenic
Index
Group A (Normal control) 89.673.77 65.331.52 241.93 52.603.66 13.060.30 2. 840.33
Group B (Hyperlipidemic control) 267.176.73a 2176.63a 16.331.17a 207.376.47a 43.401.33a 15.841.39a
Group C (HFD+ AEBS 100 mg/kg) 90.671.52b 80.671.45b 26.831.38b 47.572.58b 16.130.29b 2.430.20b
Group D (HFD+ AEBS 200 mg/kg) 81.831.22b 59.670.99b 30.001.39b 39.901.79b 11.930.20b 1.760.12b
Group E (HFD+ Simvastatin) 74.833.76 55.171.72 36.502.79 27.305.58 11.030.34 1.140.26
ANOVA
F 434.4
4,25
< 0.01
449.5
4,25
< 0.01
16.64
4,25
< 0.01
289.2
4,25
< 0.01
449.5
4,25
< 0.01
88.91
4,25
< 0.01
Df
p
Values are expressed as MEAN ± SEM; (n=6).
Test Result of Serum Lipids in mg/dl and Atherogenic index in ratio.
One Way ANOVA followed by Dunnett’s multiple comparison tests.
a: p < 0.001 when compared with Normal Control Group
b : p < 0.001 when compared with Hyperlipidaemic Control Group
Table 2: Atherogenic index and percentage of protection in various 
groups
Groups Atherogenic Index Protection %
Group- A 2. 84 ------
Group- B 15.84 ------
Group- C 2.43 85.48%
Group- D 1.76 88.89%
Group- E 1.14 92.80%
The results reveal that there was a significant increase in all 
the  lipid  parameters  (p < 0.01)  except  HDL  following 
administration  of  high  fat  diet  when  compared  to  normal 
group. It was also seen that concomitant administration of the 
AEBSL at a dose of 100 mg/kg and 200 mg/kg body weight 
along with HFD fed animals, showed a significant decrease 
in all the lipid parameters (p < 0.01) with a significant rise in  
HDL (p < 0.01) level as compared to hyperlipidemic control 
animals. 
Standard  drug  simvastatin,  at  a  dose  of  1.8  mg/kg 
administered along with high fat diet, showed a significant 
decrease (p < 0.01) in all the lipid parameters while there was 
a significant (p < 0.01) increase in HDL level. Both the doses 
of AEBS (100 mg/kg and 200 mg/kg body weight) treated 
animals  showed  decrease  in  the  atherogenic  index  and 
increased  in  percentage  of protection.  The  Hypolipidaemic 
activity  of  the  test  drug  AEBSL  was  found  to  be  less 
efficacious  than  that  of  the  standard  drug  simvastatin  in 
comparison to the control. Fig. 1 & Fig. 2 are the graphical 
representation of lipid profiles and percentage of protection 
in different groups respectively.
DISCUSSION
Elevated  levels  of  all  lipoproteins  except  the  HDL  are 
associated with increased risk of atherosclerosis. High level 
of triglycerides and LDL are associated with coronary artery 
disease 
[23], which is seen in Group B - HFD fed rats. AEBSL 
treated  rats  significantly  reduced  (P<0.01)  TC  and  TG 
concentration at both the doses administered when compared 
with experimental  controls animals.  Thus, the  reduction in 
serum  TC concentration  effected  by  the  extract  AEBSL  is 
beneficial and may reduce the risk of cardiovascular disease. 
Those  agents  that  have  the  ability  to  lower  cholesterol
concentration  in  the  blood  have  been  reported  to  reduce 
vascular resistance by improving endothelial function.  The 
endothelium  is  intimately  involved  in  the  pathogenesis  of 
atherosclerosis.  Oxidative  modification  of  LDL  by  the 
endothelium  is  thought  to  be  an  important  step  in  the 
initiation  of  atherosclerosis.  Oxidized  LDL  impairs 
endothelium-mediated  relaxation  in  isolated  arterial 
segments.  Hypercholesterolemia  and  atherosclerosis  impair 
endothelium-mediated  vasodilator  responses  in  animal 
models  and  humans.  This  loss  of  endothelium-mediated 
vasodilatation is thought to be involved in the pathogenesis 
of myocardial ischemia.
[24]
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Fig. 1: Effects of AEBSL on Serum Lipids at the end of 8th Week
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The LDL which is popularly known as the “bad cholesterol” 
is highly atherogenic
[25], because they are primary carriers of 
plasma  cholesterol  and  builds  up  slowly  in  the  walls  of 
arteries  feeding the  heart  and  brain.  As  a  result  of this,  it 
forms  plaque  that  clots  the  arteries  hereby  causing 
atherosclerosis and increasing the risk of high blood pressure 
which may eventually lead to stroke.
[26] Our results clearly 
showed  that  AEBSL  treated  rats  significantly  reduced 
(P<0.01) LDL concentration at both the doses administered 
when compared with hyperlipidemic controls animals.
The HDL is considered to have anti-atherogenic properties, 
since there is negative correlation between HDL and risk of 
cardiovascular  disease.  It  is  referred  to  as  the  ‘good’ 
cholesterol  because,  HDL  is  involved  in  transport  of 
cholesterol  from  peripheral  tissues  to  liver  and  thereby 
reducing the amount stored in the tissue and the possibility of 
developing atherosclerotic plaques.
[26] HDL was increased in 
our study significantly (P<0.01) in Group C, Group D and 
Group  E  when  compared  with  hyperlipidemic  controls 
animals  and  decreased  significantly  (P<0.01)  in  Group  B 
when compared with normal controls animals. This indicates 
that  AEBSL  may  help  to  increase  transport  of  peripheral 
tissue  cholesterol  to  liver  and  thereby  decrease  blood 
cholesterol when concomitantly fed with HFD. Many experts 
believe  that  hypertriglyceridaemia,  which  is  frequently  a 
result  of  elevated  VLDL  level,  is  indeed  a  marker  for  an 
increased  risk  for  coronary  artery  disease,  especially  in 
diabetic patient and female subjects, although this risk may 
not be as great as that for an elevated LDL or low HDL.
[25]
The  atherogenic  index  is  the  ratio,  can  be  calculated  as 
TC/HDL,  Non  HDL- Cholesterol/  HDL,  LDL/HDL, 
TG/HDL.  Non  HDL- Cholesterol  is  calculated  as  (TC-
HDL).
[27] A total cholesterol /HDL ratio of 3 connotes a 
low risk, a ratio of around 4.5 an average risk and ratio of  
8 a high risk of developing coronary artery disease.
[25] Non-
HDL  cholesterol  index  may be  particularly  useful  in 
predicting  cardiovascular  disease  risk  in  patients  with 
diabetes. 
[28] In  our  study,  atherogenic  index  is  decreased 
significantly (p < 0.01) in Group C, Group D and Group E 
when compared with hyperlipidemic group animals.
A 1% decrease in HDL   is associated with a 3-4% increase 
in  the  risk  of  heart  disease.
[22] In  the  present  study  an 
increase  in  plasma  HDL  with  a  concomitant  increase  in 
percentage  of  protection  in  atherogenesis  was  observed 
(Table 2 & Fig. 2). By the end of the experimental period, 
100  mg/kg,  200mg/kg  and  the  standard  drug  simvastatin 
increased the percentage of protection by 85.48 %, 88.89% 
and 92.80% respectively.
Major  complications  of  Diabetes  include  aberrant  lipid 
metabolism and vascular wall function. Since alterations in 
serum lipid profiles are known in diabetes which is likely to 
increase  the  risk  of  coronary  heart  disease,  a  reduction  in 
serum lipids, particularly TC, LDL and TG levels should be 
considered as beneficial in long-term prognosis  of diabetic 
patients. AEBS extract will thus have a potential therapeutic 
value  in  combating  multifactorial  atherosclerotic  disorders, 
which  are  parts  of  the  major  complications  of  Diabetes. 
Reducing  the  risk  of  atherosclerosis  will  thus  lead  to  the 
development  of  effective  and  better  management  of 
hyperlipidemia.
[16] D-pinitol  (3-O-methyl-chiroinositol),  an 
active  principle  of  the  traditional  antidiabetic  plant  BS,  is 
claimed to exert insulin-like effects. D-pinitol might exert an 
insulin-like effect on glucose transport that is independent of 
insulin. By analogy with D-chiroinositol, there is a structural 
similarity of D-pinitol with inositol phosphates involved in 
the  signaling  of  insulin  via  PI3K  and  protein  kinase  B 
pathway.  D-pinitol exerts an acute and chronic insulin-like 
antihyperglycaemic effect in diabetic mice. The mechanism 
of action of D-pinitol does not augment the effect of insulin 
but  might  involve  an  interaction  with  part  of  a  cellular 
signalling pathway that links insulin with glucose transport.
[13] This may be the possible mechanism for decreased lipid 
levels  by  AEBS  (insulin  mimicking  action),  because  a 
principal action of insulin in adipose tissue is to inhibit the 
activity of the hormone-sensitive lipase, reducing the release 
of fatty acids as well as glycerol.
[29]
Despite it has beneficial effects on lowering blood glucose as 
well  as  lowering  serum  lipid  profile,  it  may  possess some 
potential  of  adverse  effects  in  liver  and  kidney  function. 
Malmo et al
[14], has provided some valuable information on 
the  safety/toxicity  of  the  consumption  of  the  absolute 
Ethanolic  extract  of  BSL.  They  found  that  the  extract 
significantly  reduced  (p< 0.05)  serum  calcium  and 
potassium; and significantly increased (p < 0.05) phosphate 
concentration  in a dose dependent manner  while it had no 
significant effect  on the  sodium concentration.  The extract 
significantly increased (p < 0.05) serum urea and creatinine 
concentrations  in  a  dose  dependent  manner  while  it 
significantly reduced (p< 0.05) serum albumin concentration. 
ALT  (alanine  aminotransferases)  activity  in  serum  and 
kidney were significantly reduced (p < 0.05) at the dose of 
100  mg/kg,  when  compared  with  controls.  Liver  AST 
(aspartate) and serum AST activity was not affected, whereas 
kidney AST activity was significantly reduced (p < 0.05) at 
both doses when compared with controls. The extract (200 
mg/kg)  also  significantly  reduced  (p <  0.05)  Ca
2+-
Mg
2+ATPase  activity  in  the  kidney  and  significantly 
increased  (p<  0.05)  kidney  Na
+-K
+ATPase  activity.  In  the 
liver,  the  extract  significantly  reduced  (p <  0.05)  Na
+-
K
+ATPase  activity  at  both  doses  administered  while  it 
significantly increased (p > 0.05) Ca
2+-Mg
2+ ATPase activity 
at the dose of 100 mg/kg when compared with controls. They 
suggest that the repeated administration of BSL extract may 
compromise the integrity of the kidney and liver and thereby 
adversely affect their normal functions.
Adebayo et al
[30], has investigated the effect  of Ethanolic 
extract  of  BSL  on  some  haematological  and  serum  lipid 
parameters in rats during a 7 day administration of the doses 
of  50, 100  and  200mg/kg  body  weight  orally.  They 
concluded  that  the  extract  has  some  beneficial  effects  in 
reduction  in  serum  cholesterol  but  adversely  affect  some 
haematological  indices, specially related  to red blood cells 
and white blood cells. 
Mishra  et  al
[12] has  given  some  clue  of  adverse 
pharmacological  effect  on  mechanism  of  action  of  BSL 
extract  on  male  and  female  reproductive  organs.  They 
evaluated  the effect of BSL  aqueous extract  on fertility of 
male and female Swiss Albino mice at the dose of 800mg/kg 
body weight for 30 days. They found that there is significant 
degeneration  of  the  both  gonads  (male>  female)  and 
declining in the titer of testosterone in males and estrogen in 
females. They also reported that, extension of reproductive 
cycle of female mice by 1-2 days with prolonged metaestrus 
and decrease in serum estrogen level where as in male total 
count  of  sperm  decreased  along  with  decrease  in  titer  of 
testosterone.  Histological  report  of  males  shows  that, Saikia et al. / Effect of Bougainvillea spectabilis Leaves on Serum Lipids ……
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reduction in diameter  of seminiferous tubules,  thickness of 
germinal epithelium and absence of sperm in the lumen of 
tubules.
Considering the entire results from this study it was observed 
that the AEBSL significantly inhibited high fat diet induced 
hyperlipidemia in  albino  rats.  On  comparison,  the 
hypolipidaemic activity of simvastatin was found to be more 
efficacious than that of AEBSL. Bougainvillea spectabilis is 
the  most  easily  available  throughout the  world,  can  be 
utilized for providing dietary management in the prevention 
of  atherosclerosis  in  hyperlipidaemic  patients  as  well  as 
Dyslipidemia associated with diabetes. Though it has some 
adverse  effect  in various  organ systems  it deserves  further 
evaluation for its dose in higher animals, from the stand point 
of  its  hypolipidaemic  as  well  as  hypoglycemic  effect  in 
therapy. It holds the hope of development of more purified 
hypolipidaemic products those have also anti-diabetic effects.
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